Quantitative Systematic Strategies’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,480
| Closed | -$251K | – | 29 |
|
|
2021
Q2 | $251K | Sell |
1,480
-2,964
| -67% | -$503K | 0.09% | 374 |
|
|
2021
Q1 | $627K | Buy |
4,444
+2,888
| +186% | +$407K | 0.1% | 324 |
|
|
2020
Q4 | $202K | Sell |
1,556
-901
| -37% | -$117K | 0.03% | 561 |
|
|
2020
Q3 | $358K | Buy |
+2,457
| New | +$358K | 0.06% | 397 |
|
|
2019
Q3 | – | Sell |
-6,477
| Closed | -$470K | – | 462 |
|
|
2019
Q2 | $470K | Buy |
+6,477
| New | +$470K | 0.09% | 261 |
|
|
2018
Q3 | – | Sell |
-5,493
| Closed | -$541K | – | 614 |
|
|
2018
Q2 | $541K | Buy |
+5,493
| New | +$541K | 0.1% | 324 |
|
|
2016
Q1 | – | Sell |
-3,189
| Closed | -$301K | – | 415 |
|
|
2015
Q4 | $301K | Buy |
+3,189
| New | +$301K | 0.08% | 747 |
|
|
2015
Q2 | – | Sell |
-3,711
| Closed | -$400K | – | 503 |
|
|
2015
Q1 | $400K | Buy |
+3,711
| New | +$400K | 0.11% | 259 |
|